BRIEF published on 09/09/2024 at 22:40, 1 year 6 months ago ABIVAX presents its 2024 half-year results Cybersecurity Abivax Half-year Results Internal Control Failures
PRESS RELEASE published on 09/09/2024 at 22:35, 1 year 6 months ago Lettre d'affirmation sur les comptes semestriels 2024 Lettre d'Affirmation Comptes Semestriels Consolidés IFRS de ABIVAX S.A. pour la période du 1 janvier 2024 au 30 juin 2024, validée par PwC Audit et Agili(3F) Audit IFRS Comptes Semestriels ABIVAX S.A. PwC Audit Agili(3F) Audit
PRESS RELEASE published on 09/09/2024 at 22:18, 1 year 6 months ago Rapport financier semestriel 2024
BRIEF published on 09/09/2024 at 22:06, 1 year 6 months ago Résultats financiers d'Abivax pour le premier semestre 2024 Résultats Financiers Biotechnologie Abivax Premier Semestre 2024 Mécanismes Immunitaires
BRIEF published on 09/09/2024 at 22:06, 1 year 6 months ago Abivax financial results for the first half of 2024 Financial Results Biotechnology Abivax First Half Of 2024 Immune Mechanisms
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 6 months ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 6 months ago Abivax présente ses résultats financiers du premier semestre 2024 Abivax présente ses résultats financiers semestriels 2024 avec une trésorerie de 222 millions d'euros au 30 juin 2024, assurant le financement jusqu'au Q4 2025 Résultats Financiers Abivax Bilan Trésorerie Dépenses
BRIEF published on 08/29/2024 at 18:05, 1 year 6 months ago ABIVAX : État des actions et des droits de vote au 31 juillet 2024 Euronext Paris Droits De Vote Actions Abivax Réglementaire
BRIEF published on 08/29/2024 at 18:05, 1 year 6 months ago ABIVAX: Status of shares and voting rights as of July 31, 2024 Euronext Paris Voting Rights Actions Abivax Regulatory
PRESS RELEASE published on 08/29/2024 at 18:00, 1 year 6 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.24. ABIVAX annonce le nombre d'actions et de droits de vote au 31.07.24, conformément aux réglementations en vigueur Euronext Paris Droits De Vote Actions Abivax Règlement Général
Published on 03/23/2026 at 14:05, 3 hours 13 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 3 hours 18 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 4 hours 13 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 46 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 4 hours 48 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 17:00, 17 minutes ago Phuket consolide sa position privilégiée pour les familles du monde entier en quête d’un lieu de résidence sûr
Published on 03/23/2026 at 15:05, 2 hours 12 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 2 hours 36 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 2 hours 47 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 08:10, 9 hours 8 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 22 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 22 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 23 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 23 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
